Kunming Pharmaceutical Group: Net profit of 350 million yuan in 2025, down 46.00% year-on-year

Kunming Pharmaceutical Group announces that in 2025, operating revenue will be 6.58B yuan, a year-on-year decrease of 21.74%. Net profit is 350 million yuan, a year-on-year decrease of 46.00%. The company plans to distribute a cash dividend of 1.8 yuan (including tax) for every 10 shares to all shareholders in 2025, with no bonus shares or capital reserve transfer to increase share capital.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin